Showing 1 - 10 of 2,393
Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged...
Persistent link: https://www.econbiz.de/10012481795
Improved health, equity, macro-economic efficiency, efficient provision of care, and client satisfaction are the common goals of the health system. The relative significance of these goals varies, however, across nations, communities, and with time. As for health care finance, the attainment of...
Persistent link: https://www.econbiz.de/10012470248
This paper explores the changing role of government involvement in health care financing policy outside the United States. It provides a review of the economics literature in this area to understand the implications of recent policy changes on efficiency, costs and quality. Our review reveals...
Persistent link: https://www.econbiz.de/10012459221
medical innovations whose returns are earned worldwide. Because world returns drive innovation and innovation is central to … countries when governments centrally price health care. Providing world returns to medical innovation under such central pricing … benefit of medical innovation. This has the direct normative implication that medical innovations have inefficiently low world …
Persistent link: https://www.econbiz.de/10012459381
During the decade 1983-1992, approximately 1.4 trillion dollars of municipal bonds were sold in 87 thousand separate issues, primarily to finance capital projects for education, electric power, transportation, health care, housing and other public and private purpose activities. Approximately...
Persistent link: https://www.econbiz.de/10012471568
Perhaps more than any other sector of the economy, healthcare depends on government resources. As a result, many healthcare systems rely on the use of government monopsony power to decrease spending. The United States is a notable exception, where prices in large portions of the healthcare...
Persistent link: https://www.econbiz.de/10012480068
There is substantial waste in U.S. healthcare, but little consensus on how to identify or combat it. We identify one specific source of waste: long-term care hospitals (LTCHs). These post-acute care facilities began as a regulatory carve-out for a few dozen specialty hospitals, but have expanded...
Persistent link: https://www.econbiz.de/10012480599
This study exploits over 5,000 variations in subsidy generosity across ages and municipalities in Japan to examine how children respond to healthcare prices. We find that free care significantly increases outpatient spending, with price elasticities considerably smaller than for adults. Price...
Persistent link: https://www.econbiz.de/10012480957
Estimates of the benefits of antifraud enforcement in health care typically focus on direct monetary damages. Deterrence effects are acknowledged but unquantified. We evaluate the impact of a Department of Justice investigation of hospitals accused of billing Medicare for unnecessary implantable...
Persistent link: https://www.econbiz.de/10012482119
Academic Medical Centers (AMCs)--comprising medical schools, teaching hospitals, and research laboratories)--play an important role in US biomedical innovation. The Balanced Budget Act of 1997 (BBA) changed the formula used to reimburse Medicare inpatient claims and subsidies for medical...
Persistent link: https://www.econbiz.de/10012482163